Home › NDC Lookup › Ingredients › Gabapentin › 71610-0088-53
Gabapentin 300 mg Capsule, 60-count — NDC 71610-0088-53 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Gabapentin 300 mg Capsule, 60-count — NDC 71610-088-53 (Billing 71610-0088-53)

by Aphena Pharma Solutions - Tennessee, LLC · 60 CAPSULE in 1 BOTTLE

This is a package of 60 capsules of Gabapentin 300 mg Capsule from Aphena Pharma Solutions - Tennessee, LLC, marketed since Dec 2015 and currently FDA-listed. It is the main listing for this product, which comes in 5 package sizes.

NDC 71610-0088-53
🏷️ FDA NDC (as labeled) 71610-088-53 billing pads the product segment with a zero
This package
Contains60-count Pack sizes5 compare ↓
Also priced by: Part D plans $0.1402/unit — full pricing hub ↓
Main listing for product 71610-088 · Also comes in: 90 capsules 71610-088-60 180 capsules 71610-088-80 270 capsules 71610-088-92 360 capsules 71610-088-94
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 71610-088-53 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
71610 labeler · 088 product · 53 package
Package marketed since
Jun 21, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
60 EA per package
Barcode (UPC-A, from the NDC)
3 7161008853 6
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Gabapentin (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 10, 2025 — Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . (The Harvard Drug Group LLC) · FDA recall D-0031-2026
Class II · Oct 10, 2025 — Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . (The Harvard Drug Group LLC) · FDA recall D-0030-2026
Class II · Jun 19, 2025 — Defective container; blister packaging inadequately sealed. (The Harvard Drug Group LLC) · FDA recall D-0507-2025
Class II · Jun 19, 2025 — Defective container; blister packaging inadequately sealed. (The Harvard Drug Group LLC) · FDA recall D-0508-2025
Class II · Mar 13, 2025 — CGMP Deviations (Glenmark Pharmaceuticals Inc., USA) · FDA recall D-0320-2025
Class III · Mar 4, 2025 — Cross Contamination (SUN PHARMACEUTICAL INDUSTRIES INC) · FDA recall D-0312-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 71610-088-53
Product NDC 71610-088
11-digit billing NDC 71610008853
NCPDP billing unit EA — each (per item)
RxCUI 310431
UNII 6CW7F3G59X
Application # ANDA090007
SPL Set ID 9d1b9121-c25a-4d28-91c5-5fc72f1167f4
Physiologic effect Decreased Central Nervous System Disorganized Electrical Activity
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-12-30
Route ORAL
Dosage form CAPSULE
Substance GABAPENTIN
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 72600030000130
GPI class Gabapentin
GCN Seq No 021414
GCN 00781
HICL code 008831
Ingredient (HICL) Gabapentin
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H4
Therapeutic class — intermediate (HIC2) Anticonvulsants
HIC3 code H4B
Therapeutic class — specific (HIC3) Anticonvulsants
AHFS code 28:08.92.00
AHFS class Analgesics And Antipyretics, Misc.
FDB label name GABAPENTIN 300 MG CAPSULE
FDB brand name Gabapentin
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 021414
  • GCN: 00781
  • GPI-14 (Medi-Span): 72600030000130
  • HICL (First Databank): 008831
  • AHFS class code: 28:08.92.00
  • RxCUI (RxNorm): 310431
Why two NDCs? The FDA registers this code as 71610-088-53 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 71610-0088-53. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Gabapentinoids class.

Drug family (ATC) Gabapentinoids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name GABAPENTIN 300 MG CAPSULE Ingredient Gabapentin
📗 Our plain-language guide HelloPharmacist
  • It's used for nerve pain after shingles (postherpetic neuralgia). Many gabapentin products are also used as add-on treatment for partial seizures in epilepsy. Horizant is also used...
  • Dizziness and sleepiness are the most common side effects. Don't drive or use heavy machinery until you know how it affects you, because you may not judge your own impairment well.
  • Talk to your prescriber first. Stopping seizure medicines suddenly can increase seizures. Gralise should be changed or stopped gradually over at least a week.
  • Tell me about any opioid or sedating medicine, because together they can slow breathing dangerously. If you use an antacid like Maalox, take gabapentin at least 2 hours after it.
📖 Read our full Gabapentin guide →
1
Nutrient depletion considerations

Gabapentin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Gabapentin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1402 $8.41 / 60 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
71610-0088-53 You're viewing this Main listing 60 CAPSULE in 1 BOTTLE 2018-06-21 — Active
71610-0088-60 71610-088-60 90 CAPSULE in 1 BOTTLE 2018-06-21 — Active
71610-0088-80 71610-088-80 180 CAPSULE in 1 BOTTLE 2018-06-21 — Active
71610-0088-92 71610-088-92 270 CAPSULE in 1 BOTTLE 2018-06-21 — Active
71610-0088-94 71610-088-94 360 CAPSULE in 1 BOTTLE 2018-06-21 — Active

You're viewing the smallest of 5 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 60-count package — 60 capsule in 1 bottle.
How does this package differ from NDC 71610-0088-60?
Both are Gabapentin 300 mg Capsule — the drug itself is identical. This page's package is the 60-count one, while NDC 71610-0088-60 is the 90 capsules package.
What NDC number is used to bill for this package of Gabapentin 300 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Gabapentin 300 mg 63739-0903-10 McKesson 100 capsules $0.030 AB Availability likely —
Gabapentin 300 mg 00480-3495-01 Teva 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 00904-6666-61 Major 100 capsules $0.031 AB Availability likely —
gabapentin 300 mg 16571-0868-01 Rising 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 16714-0662-01 NorthStar 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 23155-0867-01 Heritage 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 31722-0149-01 Camber 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 42385-0973-01 Laurus 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 45963-0556-11 Actavis 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 49483-0606-01 TIME 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 50228-0180-01 ScieGen 100 capsules $0.031 AB Availability likely —
Relgaabi 300 mg 58657-0233-01 Method 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 60687-0591-01 American 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 64380-0754-01 Strides 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 65862-0199-01 Aurobindo 100 capsules $0.031 — Availability likely —
Gabapentin 300 mg 67877-0223-01 Ascend 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 69292-0641-01 Amici 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 69367-0132-06 Westminster 500 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 69367-0344-05 Westminster 500 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 70010-0927-01 Granules 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 71093-0121-04 ACI 100 capsules $0.031 AB Discontinued —
Gabapentin 300 mg 83301-0004-01 Mullan 100 capsules $0.031 AB Availability likely —
Gabapentin 300 mg 70010-0109-01 Granules 100 capsules $0.034 AB Discontinued —
Gabapentin 300 mg 64380-0868-06 Strides 100 capsules $0.041 AB FDA listed —
Gabapentin 300 mg 69097-0943-07 Cipla 100 capsules $0.041 AB FDA listed —
Neurontin 300 mg 00071-0805-24 Parke-Davis 100 capsules $7.371 AB Availability likely —
Neurontin 300 mg 58151-0282-01 Viatris 100 capsules $7.371 AB Availability likely —
Gabapentin 300 mg 00904-7614-61 Major 100 capsules — AB FDA listed —
Gabapentin 300 mg 25000-0104-03 MARKSANS 30 capsules — AB FDA listed —
Gabapentin 300 mg 42582-0115-10 Bi-Coastal 100 capsules — AB FDA listed —
Gabapentin 300 mg 42806-0510-01 Epic 100 capsules — AB FDA listed —
Gabapentin 300 mg 43063-0673-30 PD-Rx 30 capsules — AB FDA listed —
Gabapentin 300 mg 43353-0075-30 Aphena 30 capsules — AB FDA listed —
Gabapentin 300 mg 43547-0480-10 Solco 100 capsules — AB FDA listed —
Gabapentin 300 mg 45865-0194-30 Medsource 30 capsules — AB FDA listed —
Gabapentin 300 mg 50090-0896-00 A-S 100 capsules — AB FDA listed —
Gabapentin 300 mg 50090-4893-00 A-S 90 capsules — AB FDA listed —
Gabapentin 300 mg 50090-6718-00 A-S 90 capsules — AB FDA listed —
Gabapentin 300 mg 50090-7420-00 A-S 100 capsules — AB FDA listed —
Gabapentin 300 mg 50090-7421-00 A-S 90 capsules — AB FDA listed —
Gabapentin 300 mg 50090-7674-00 A-S 100 capsules — AB FDA listed —
Gabapentin 300 mg 50090-7675-00 A-S 90 capsules — AB FDA listed —
Gabapentin 300 mg 51407-0048-10 Golden 1000 capsules — AB Discontinued —
Gabapentin 300 mg 53746-0102-01 Amneal 100 capsules — AB FDA listed —
Gabapentin 300 mg 55154-7992-00 Cardinal 10 capsules — AB FDA listed —
Gabapentin 300 mg 55154-8195-00 Cardinal 10 capsules — AB FDA listed —
Gabapentin 300 mg 55700-0949-01 Quality 120 capsules — AB FDA listed —
Gabapentin 300 mg 58118-1102-08 Clinical 30 capsules — AB FDA listed —
Gaba 300-EZS 59088-0725-00 PureTek 100 capsules — — FDA listed —
Gabapentin 300 mg 60760-0674-30 St. 30 capsules — AB FDA listed —
Gabapentin 300 mg 60760-0741-60 St. 60 capsules — AB FDA listed —
Gabapentin 300 mg 60760-0814-60 St 60 capsules — AB FDA listed —
Gabapentin 300 mg 61919-0640-30 DIRECT 30 capsules — AB FDA listed —
gabapentin 300 mg 62756-0138-01 Sun 50 capsules — — FDA listed —
Gabapentin 300 mg 63187-0810-00 Proficient 100 capsules — AB FDA listed —
Gabapentin 300 mg 63187-0988-00 Proficient 100 capsules — AB FDA listed —
Gabapentin 300 mg 63629-7306-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 63629-8486-01 Bryant 500 capsules — AB FDA listed —
Gabapentin 300 mg 63629-8487-01 Bryant 100 capsules — AB FDA listed —
Gabapentin 300 mg 65162-0102-03 Amneal 30 capsules — AB FDA listed —
Gabapentin 300 mg 67046-1284-03 Coupler 30 capsules — AB FDA listed —
Gabapentin 300 mg 67046-1429-03 Coupler 30 capsules — AB FDA listed —
Gabapentin 300 mg 68071-2366-01 NuCare 100 capsules — AB FDA listed —
Gabapentin 300 mg 68071-2876-09 NuCare 90 capsules — AB FDA listed —
Gabapentin 300 mg 68071-3527-03 NuCare 30 capsules — AB FDA listed —
Gabapentin 300 mg 68071-4784-01 NuCare 100 capsules — AB FDA listed —
Gabapentin 300 mg 68071-5193-03 NuCare 30 capsules — AB FDA listed —
Gabapentin 300 mg 68788-7024-01 Preferred 100 capsules — AB FDA listed —
Gabapentin 300 mg 68788-7848-00 Preferred 100 capsules — AB FDA listed —
Gabapentin 300 mg 68788-8712-00 Preferred 100 capsules — AB FDA listed —
Gabapentin 300 mg 69434-0043-03 Zhejiang 500 capsules — AB FDA listed —
Gabapentin 300 mg 70518-0293-00 REMEDYREPACK 90 capsules — AB FDA listed —
Gabapentin 300 mg 70518-1760-04 REMEDYREPACK 30 capsules — AB FDA listed —
Gabapentin 300 mg 70518-2970-00 REMEDYREPACK 30 capsules — AB Discontinued —
Gabapentin 300 mg 70518-3329-00 REMEDYREPACK 100 capsules — AB FDA listed —
Gabapentin 300 mg 70518-4411-00 REMEDYREPACK 90 capsules — AB FDA listed —
Gabapentin 300 mg 71205-0295-15 Proficient 15 capsules — AB FDA listed —
Gabapentin 300 mg 71205-0532-14 Proficient 14 capsules — AB FDA listed —
Gabapentin 300 mg 71205-0766-30 Proficient 30 capsules — AB FDA listed —
Gabapentin 300 mg 71205-0929-00 Proficient 100 capsules — AB FDA listed —
Gabapentin 300 mg 71335-0220-00 Bryant 20 capsules — AB Discontinued —
Gabapentin 300 mg 71335-0993-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1093-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1197-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1269-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1348-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1453-00 Bryant 20 capsules — AB Discontinued —
Gabapentin 300 mg 71335-1454-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1490-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-1997-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-2004-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-2280-01 Bryant 1000 capsules — AB FDA listed —
Gabapentin 300 mg 71335-2521-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-2699-00 Bryant 20 capsules — AB FDA listed —
Gabapentin 300 mg 71335-2748-01 Bryant 90 capsules — AB FDA listed —
Gabapentin 300 mg 71335-3109-01 Bryant 500 capsules — AB FDA listed —
Gabapentin 300 mgthis 71610-0088-53 Aphena 60 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0143-60 Aphena 90 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0146-30 Aphena 30 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0185-30 Aphena 30 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0188-30 Aphena 30 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0211-60 Aphena 90 capsules — AB FDA listed —
Gabapentin 300 mg 71610-0753-70 Aphena 120 capsules — AB FDA listed —
Gabapentin 300 mg 72162-1533-01 Bryant 100 capsules — AB FDA listed —
Gabapentin 300 mg 72162-1813-01 Bryant 100 capsules — AB FDA listed —
Gabapentin 300 mg 72162-2139-01 Bryant 100 capsules — AB FDA listed —
Gabapentin 300 mg 72189-0392-30 Direct_Rx 30 capsules — AB FDA listed —
Gabapentin 300 mg 72189-0610-30 Direct_Rx 30 capsules — AB FDA listed —
Gabapentin 300 mg 72737-0006-01 STALLION 30 capsules — AB FDA listed —
Gabapentin 300 mg 72789-0055-30 PD-Rx 30 capsules — AB FDA listed —
Gabapentin 300 mg 72865-0253-05 XLCare 500 capsules — AB FDA listed —
Gabapentin 300 mg 76282-0627-01 Exelan 100 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0015-24 Asclemed 240 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0020-24 Asclemed 240 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0047-12 Asclemed 120 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0617-10 Asclemed 100 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0789-01 Asclemed 100 capsules — AB FDA listed —
Gabapentin 300 mg 76420-0869-01 Asclemed 100 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0031-01 ADVANCED 30 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0032-01 Advanced 30 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0033-01 Advanced 30 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0079-01 Advanced 30 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0182-01 Advanced 30 capsules — AB FDA listed —
Gabapentin 300 mg 80425-0196-01 Advanced 30 capsules — AB FDA listed —
Gabapentin 300 mg 82619-0143-01 Creekwood 100 capsules — AB FDA listed —
Gabapentin 300 mg 82804-0206-90 Proficient 90 capsules — AB FDA listed —
Gabapentin 300 mg 82804-0217-30 Proficient 30 capsules — AB FDA listed —
Gabapentin 300 mg 82868-0051-30 Northwind 30 capsules — AB FDA listed —
gabapentin 300 mg 82868-0073-30 Northwind 30 capsules — AB FDA listed —
Gabapentin 300 mg 85509-2180-01 PHOENIX 100 capsules — AB FDA listed —
Gabapentin 300 mg 87441-0035-01 Unit 30 capsules — AB FDA listed —
Gabapentin 300 mg 85534-0056-00 HAWAII 30 capsules — AB FDA listed —
Gabapentin 300 mg 85534-0007-00 HAWAII 30 capsules — AB FDA listed —
Gabapentin 300 mg 70518-2911-00 REMEDYREPACK 100 capsules — AB Discontinued —
Gabapentin 300 mg 60760-0940-60 St. 60 capsules — AB FDA listed —
gabapentin 300 mg 67046-1644-03 Coupler 30 capsules — AB FDA listed —
Gabapentin 300 mg 82868-0109-30 Northwind 30 capsules — AB FDA listed —
Gabapentin 300 mg 67296-2299-04 Redpharm 21 capsules — AB FDA listed —
gabapentin 300 mg 68071-5317-01 NuCare 100 capsules — AB FDA listed —
Gabapentin 300 mg 55154-0580-00 Cardinal 10 capsules — AB FDA listed —
Gabapentin 300 mg 70518-4746-00 REMEDYREPACK 30 capsules — AB FDA listed —
gabapentin 300 mg 70518-4763-00 REMEDYREPACK 100 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Dec 2015
📍
2026
Currently FDA-listed
11 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
Shapecapsule
Imprint104
Size19 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAphena Pharma Solutions - Tennessee, LLC
Application holderMARKSANS PHARMA LTD
FDA applicationANDA090007 (ANDA)
Labeler code71610
First marketedDec 2015
Product typeHuman Prescription Drug
Portfolio800 products on file

More NDCs from Aphena Pharma Solutions - Tennessee, LLC labeler code 71610

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Very long sections are excerpted here and marked; the full text is on DailyMed (linked in the sources below). Jump with a chip, search within the label, or expand everything.
📦 How Supplied / Storage and Handling 💬 Medication Guide 📄 Package Label / Principal Display Panel
📦 How Supplied / Storage and Handling 93 words ▾

HOW SUPPLIED 100 mg Capsules (White/White colored, size '3' hard gelatin capsules with "103" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

HOW SUPPLIED 300 mg Capsules (Yellow/Yellow colored, size '1' hard gelatin capsules with "104" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

HOW SUPPLIED 400 mg Capsules (Orange/Orange colored, size '0' hard gelatin capsules with "105" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

💬 Medication Guide ~3 min read ▾

MEDICATION GUIDE Gabapentin Capsules, USP Gabapentin Tablets, USP (gab'' a pen' tin) What is the most important information I should know about gabapentin? Do not stop taking gabapentin without first talking to your healthcare provider. Stopping gabapentin suddenly can cause serious problems.

Gabapentin can cause serious side effects including: 1. Suicidal Thoughts. Like other antiepileptic drugs, gabapentin may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.

Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: • thoughts about suicide or dying • attempts to commit suicide • new or worse depression • new or worse anxiety • feeling agitated or restless • panic attacks • trouble sleeping (insomnia) • new or worse irritability • acting aggressive, being angry, or violent • acting on dangerous impulses • an extreme increase in activity and talking (mania) • other unusual changes in behavior or mood How can I watch for early symptoms of suicidal thoughts and actions? • Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. • Keep all follow-up visits with your healthcare provider as scheduled.

Call your healthcare provider between visits as needed, especially if you are worried about symptoms. Do not stop taking gabapentin without first talking to a healthcare provider. • Stopping gabapentin suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus). • Suicidal thoughts or actions can be caused by things other than medicines.

If you have suicidal thoughts or actions, your healthcare provider may check for other causes. 2. Changes in behavior and thinking - Using gabapentin in children 3 to 12 years of age can cause emotional changes, aggressive behavior, problems with concentration, restlessness, changes in school performance, and hyperactivity.

3. Gabapentin may cause serious or life-threatening allergic reactions that may affect your skin or other parts of your body such as your liver or blood cells. This may cause you to be hospitalized or to stop gabapentin.

You may or may not have a rash with an allergic reaction caused by gabapentin. Call a healthcare provider right away if you have any of the following symptoms: • skin rash • hives • difficulty breathing • fever • swollen glands that do not go away • swelling of your face, lips, throat or tongue • yellowing of your skin or of the whites of the eyes • unusual bruising or bleeding • severe fatigue or weakness • unexpected muscle pain • frequent infections These symptoms may be the first signs of a serious reaction. A healthcare provider should examine you to decide if you should continue taking gabapentin.

What is gabapentin? Gabapentin is a prescription medicine used to treat: • Partial seizures when taken together with other medicines in adults and children 3 years of age and older with seizures. Who should not take gabapentin?

Do not take gabapentin if you are allergic to gabapentin or any of the other ingredients in gabapentin. See the end of this Medication Guide for a complete list of ingredients in gabapentin. What should I tell my healthcare provider before taking gabapentin?

Before taking gabapentin, tell your healthcare provider if you : • have or have had kidney problems or are on hemodialysis • have or have had depression, mood problems, or suicidal thoughts or behavior • have diabetes • are pregnant or plan to become pregnant. It is not known if gabapentin can harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking gabapentin.

You and your healthcare provider will decide if you should take gabapentin while you are pregnant. o Pregnancy Registry: If you become pregnant while taking gabapentin, talk to your healthcare provider about registering with the North American Anti… [Excerpted — this section continues on DailyMed.]

📄 Package Label / Principal Display Panel 19 words ▾

PRINCIPAL DISPLAY PANEL - 300 mg NDC 71610-088 - Gabapentin 300 mg - Rx Only Bottle Label 300 mg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Gabapentin — the program that covers self-administered drugs. 41 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Gabapentin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$151.2M
Claims incl. refills
8.9M
Beneficiaries
5.1M
Spend / beneficiary
$29.73
Spend / claim
$16.90
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aphena Pharma Solutions - Tennessee, LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 90 capsules (71610-0088-60), 180 capsules (71610-0088-80), 270 capsules (71610-0088-92). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aphena Pharma Solutions - Tennessee, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 71610-0083-30 · Aphena 71610-0092-15 · Aphena →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.